Neogen Chemicals Reports Robust Q4 FY26 Performance; Recommends Dividend of INR 1 Per Share

Neogen Chemicals Reports Robust Q4 FY26 Performance; Recommends Dividend of INR 1 Per Share​

Neogen Chemicals Limited reported a strong financial performance for the fourth quarter and full year ending March 31, 2026. The company announced a final dividend recommendation of INR 1 per equity share for FY26, subject to shareholder approval.

In the fourth quarter of FY26, consolidated revenues stood at INR 247 crore, marking a 22% increase year-over-year (Y-o-Y). The company attributed its robust performance to rising volumes and sustained high plant utilization, which helped counteract industry headwinds, elevated input costs, and geopolitical supply chain disruptions.

Consolidated EBITDA for Q4 FY26 reached INR 44 crore, rising by 21% Y-o-Y, while consolidated margins sustained at 17.8%. Profit after tax (PAT) for the quarter was INR 11 crore. The consolidated Earnings per share (EPS) for Q4 FY26 was INR 4.32 per share (not annualized).

The company noted that the base quarter included one-off expenses related to a Dahej fire incident, contributing to a low base for the Y-o-Y comparison. The Board of Directors recommended the dividend of INR 1 per equity share for FY26 based on the strong overall financial results.

Performance Metrics Overview​

The following table provides a detailed comparison of the company's consolidated financial results for Q4 FY26 and the full year FY26.


Note: Growth for Q4 FY26 is compared to Q4 FY25. Full Year FY26 is compared to FY25.

Strategic Growth and Expansion Initiatives​

The company’s performance was also supported by Neogen Ionics (NIL), which reported Q4 FY26 revenue of INR 13 crore.

Dr. Harin Kanani, Managing Director of Neogen Chemicals, commented on the sustained operational resilience, stating that the growth was driven by high plant throughput and stable demand visibility across both core and emerging applications. He emphasized that input cost inflation remains mostly a pass-through, protecting core profitability.

Key Updates and Investments:

• The reconstruction of the replacement plant is on track, with commissioning expected by June 2026.
• The Board approved a preferential allotment of 10 lakh equity shares to a promoter group entity, aggregating INR 161 crore. This investment supports the expansion into high-growth segments like battery materials.
• As of date, the cumulative on-account insurance claim received stands at INR 140 crore, with a net claim receivable of INR 203 crore.

Expansion Projects:
Neogen Chemicals is advancing its capabilities in Battery Chemicals. The company has established several capacity expansion plans:


Neogen Ionics and Future Outlook:
The Pakhajan Greenfield Project remains on track for commercial manufacturing of Electrolytes in H1 FY27 and Electrolyte Salts in H2 FY27. Mechanical assembly is complete for the Electrolyte plant, which has moved to the trial-run phase to ensure process stabilization.

Furthermore, for Electrolyte Salts, provisional approvals have been received from additional international customers, and final site audits are underway.

Looking ahead, the company anticipates FY27 will be transformative. Management expressed confidence in achieving standalone revenues in the range of INR 875 -950 crore in FY27, factoring in MPP-5 full production from Q2 FY26. The company also highlighted that Neogen Ionics' Dahej plant received audit approval from three US-based electrolyte makers and is set to scale up during this year.

NEOGEN Stock Price Movement​

On Friday, Neogen Chemicals Limited shares shed 1.31% of their value, settling at ₹1664.8. The stock saw a total traded volume of 17,089 shares as it closed below its previous day's opening level.